Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry

Zhanjun Ma, Zhenguo Li, Huan Wang, Renjun Wang, Xiaofei HanChinese 2022 · DOI

TL;DR

This study identifies three key serum metabolites – 4β-hydroxycholesterol (4β-OHC), cholestane-3β,5α,6β-triol (Triol), and cholesterol – as promising biomarkers for early colon cancer (CC) detection. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and advanced statistical analysis, the researchers achieved a highly accurate prediction of CC, paving the way for less invasive diagnostic tools.

What Problem Does This Paper Address?

Colon cancer (CC) is a significant global health concern, with increasing incidence rates. Current diagnostic methods, while effective, often involve invasive procedures like colonoscopies. The lack of readily available, non-invasive biomarkers for early detection and monitoring hinders timely intervention, leading to poorer patient outcomes. Cholesterol and its oxidized derivatives, oxysterols, are known to play roles in various cancers, suggesting their potential as diagnostic markers. This paper aims to identify specific oxysterols in serum that can reliably distinguish CC patients from healthy individuals.

Methods

The core of this study relies on Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) to simultaneously quantify cholesterol and ten related oxysterol metabolites in serum samples. After sample preparation involving derivatization to enhance ionization, the samples were analyzed using a high-resolution LC-MS/MS system.

For data analysis, the researchers employed a multi-pronged approach:

  • Statistical Analysis: Raw data was processed using GraphPad Prism for initial analysis.
  • Multivariate Statistical Analysis: Partial Least-Square Discriminant Analysis (PLS-DA) and Orthogonal Partial Least-Square Discriminant Analysis (OPLS-DA) were used. These are supervised learning techniques that help identify patterns and differences between groups (CC patients vs. healthy controls) by projecting high-dimensional data onto a lower-dimensional space. OPLS-DA is particularly useful for filtering out noise and focusing on variables relevant to the experimental outcome.
  • Biomarker Selection: To avoid overfitting and identify robust biomarkers, a combination of Variable Importance in the Projection (VIP) scores (a measure of a metabolite's contribution to the PLS-DA model), optimal component selection (determined through cross-validation), and K-means clustering was used.
  • Diagnostic Performance Evaluation: A Receiver Operating Characteristic (ROC) curve was generated for the selected biomarkers. The Area Under the Curve (AUC) quantifies the diagnostic accuracy of a test; an AUC closer to 1 indicates better performance.
  • Pathway Analysis: Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed on genes associated with the identified biomarkers to understand their biological roles and involvement in CC pathogenesis.

Datasets

The study utilized serum samples from:

  • Colon Cancer (CC) patients: 13 individuals.
  • Healthy Controls (HC): 29 individuals.

These samples were collected from The Second Hospital of Dalian Medical University. The paper also references publicly available databases like GeneCards and MetaboAnalyst for gene and pathway analysis.

Key Insights and Ideas

  • Oxysterols as potential CC biomarkers: The study demonstrates that specific oxysterols, alongside cholesterol, can serve as reliable indicators of colon cancer. This moves beyond traditional markers and offers a new avenue for non-invasive diagnostics.
  • Synergistic diagnostic power: The combination of just three metabolites (4β-OHC, Triol, and cholesterol) achieved an exceptionally high diagnostic accuracy (AUC of 0.998). This highlights the power of multi-metabolite panels for disease detection.
  • Metabolic pathways implicated in CC: The pathway analysis reveals that the identified biomarkers are involved in crucial biological processes like cholesterol metabolism, transport, and steroid biosynthesis. This provides a deeper understanding of how these molecules might contribute to CC development.
  • LC-MS/MS as a powerful tool: The study showcases the effectiveness of LC-MS/MS in simultaneously analyzing a panel of related metabolites, enabling comprehensive metabolomic profiling for biomarker discovery.

Key Results

  • Biomarker Identification: Three key serum metabolites were identified as potential biomarkers for colon cancer: 4β-hydroxycholesterol (4β-OHC), cholestane-3β,5α,6β-triol (Triol), and cholesterol.
  • High Diagnostic Accuracy: The combined ROC curve analysis of these three biomarkers yielded an AUC of 0.998, indicating excellent diagnostic performance in distinguishing CC patients from healthy controls.
  • Metabolite Involvement: GO enrichment analysis showed that the identified biomarkers are primarily involved in cholesterol metabolism, transport, and low-density lipoprotein particle remodeling. KEGG pathway analysis highlighted their enrichment in steroid biosynthesis, PPAR signaling, and ABC transporter pathways.
  • PLS-DA/OPLS-DA Efficacy: The PLS-DA and OPLS-DA models effectively separated the CC and HC groups, demonstrating the discriminative power of the analyzed metabolites.

Limitations and Future Work

  • Sample Size: The study utilized a relatively small sample size (13 CC patients and 29 healthy controls). While the results are promising, a larger, more diverse cohort is needed for validation.
  • Prospective Validation: The authors suggest that further prospective studies are necessary to validate these findings in a broader population and to assess their utility in clinical settings for early diagnosis and monitoring.
  • Mechanism Elucidation: While the study identifies pathways involved, further research is needed to fully elucidate the precise mechanisms by which these oxysterols contribute to the pathogenesis of colon cancer.

Summary updated

Abstract

Colon cancer (CC) is one of the most common malignant tumors worldwide. As there are no effective biomarkers for the early diagnosis and intervention tracking, the incidence of CC is increasing every year. Cholesterol is an important component of cell membrane, and it has been shown to be associated with CC. Oxysterol is an oxidized derivative of cholesterol, which plays an important role in many malignant tumors. In this study, liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to determine serum cholesterol and ten oxysterol metabolites related to cholesterol in CC patients and healthy controls, and qualitative and quantitative analyses were carried out. Raw data were processed and analyzed using GraphPad Prism 8.3.0 and the MetaboAnalyst 5.0 platform (https://www.metaboanalyst.ca/MetaboAnalyst/ModuleView.xhtml). To perform the independent sample <i>t</i>-test, it was necessary to ensure that all the sample data followed a normal distribution; therefore, the normal distribution test was performed in advance. The Mann-Whitney U test, which is a nonparametric test, was adopted for samples without a normal distribution. For the processed data, we used the statistical analysis function module of the MetaboAnalyst 5.0 platform to perform partial least-square discriminant analysis (PLS-DA) and orthogonal partial least-square discriminant analysis (OPLS-DA). Both PLS-DA and OPLS-DA are supervised discriminant analysis methods. The OPLS-DA model is based on the PLS-DA model and eliminates variables that are unrelated to the experiment. In both models, the samples from the two groups were well separated by the score plot. In the PLS-DA model, the horizontal and vertical coordinates of the score plot represent the interpretation rates of the principal components of the model. The horizontal coordinates show the differences between groups, and the vertical coordinates show the differences within groups. In addition to the score plot in the PLS-DA model, another crucial factor is variable importance in the projection (VIP). When VIP>1, the compound makes an important contribution to the model and is also used as a criterion for screening differential metabolites. Based on 10-fold cross-validation (CV) of the PLS-DA model, the performance of the model was the best when the number of components was three. To avoid overfitting of the data, three metabolic markers were selected by using not only the VIP values of metabolites of the PLS-DA model, but also the optimal compositions and <i>K</i>-mean clusters. The three biomarkers were 4<i>β</i>-hydroxycholesterol (4<i>β</i>-OHC), cholestane-3<i>β</i>,5<i>α</i>,6<i>β</i>-triol (Triol), and cholesterol. A receiver operating characteristic (ROC) curve was constructed. The area under the curve (AUC) was generally between 0.5 and 1.0. In the case of AUC>0.5, the closer the AUC is to 1, the better is the performance of the model. In this study, the area under the ROC curve constructed jointly by the three metabolic markers was 0.998, indicating that their combined ability to predict CC was strong and that the diagnostic performance was excellent. In addition, to understand the role of the three metabolic markers in the pathogenesis of CC, the genes associated with the metabolic markers were identified using GeneCards (https://www.genecards.org/). Finally, 110 genes were identified. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to analyze the biological processes, metabolic pathways, and possible roles in the body. GO enrichment showed that the three markers are mainly distributed in the endoplasmic reticulum lumen and coated vesicles, and they are mainly involved in biological processes such as cholesterol metabolism, transportation, and low-density lipoprotein particle remodeling. Their molecular functions are cholesterol transfer activity and low-density lipoprotein particle receptor binding. KEGG pathway analysis showed that biomarkers are enriched in steroid biosynthesis, PPAR (peroxisome proliferator-activated receptor) signaling pathways, and ABC (ATP-binding cassette) transport pathways. The results of this study are helpful to understand the role of cholesterol and oxysterol in the pathogenesis of CC and to elucidate the pathogenesis of CC.
BibTeX
@inproceedings{ma2022screening,
  author = {Zhanjun Ma and Zhenguo Li and Huan Wang and Renjun Wang and Xiaofei Han},
  title = {{Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry}},
  booktitle = {Chinese},
  year = {2022},
  doi = {10.3724/sp.j.1123.2022.01001},
}
Figure